Investing.com -- AstraZeneca shares fell Thursday after an outside panel of experts to the U.S. Food and Drug Administration ...
Ron and Michele Christoforo are suing the VA over a law that only grants Agent Orange birth defect benefits to children of ...
Phase I/II clinical trial interim results, out to 168 days, from the two RV-001 dosing cohorts with advanced Retinitis ...
Researchers at the Mayo Clinic and startup Goodfire have demonstrated an AI model, Evo 2, that can predict which genetic mutations cause disease and explain the underlying biological reasons. Using AI ...
Researchers developed and externally validated integrated polygenic risk scores for eight cardiovascular conditions using ...
During the early stages of a pandemic, viruses tend to evolve in ways that enhance their ability to reproduce and spread, ...
How do our genes determine our appearance and our susceptibility to disease? This question is central to biomedical research, ...
In his new book, *On the Future of Species*, Adrian Woolfson describes artificial biological intelligence (ABI) as technology capable of designing genetic sequences and potentially assembling living ...
Switching to camizestrant 75 mg while continuing CDK4/6i significantly prolonged PFS to 16.0 vs 9.2 months (HR 0.44; P<.00001 ...
Most hypotheses suggest that earlier forms of life had partial genetic codes and used fewer than 20 amino acids. To test ...
Growing demand for sensitive and accurate nucleic acid detection, wider use in clinical diagnostics and personalized medicine ...
Drug repurposing could help find a treatment for multiple sulfatase deficiency, a rare genetic disease that currently has no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results